FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1497133247> ?p ?o ?g. }

• W1497133247 endingPage "5839" @default.
• W1497133247 startingPage "5839" @default.
• W1497133247 abstract "Non-alcoholic fatty liver disease (NAFLD) has been recognized as a major health burden. It is the most important cause of chronic liver disease and a major independent cardiovascular risk factor. Lacking a definite treatment for NAFLD, a specific diet and an increase in physical activity represent the most commonly used therapeutic approaches. In this review, major literature data about the use of omega-3 polyunsaturated fatty acids (n-3 PUFAs) as a potential treatment of NAFLD have been described. n-3 PUFAs, besides having a beneficial impact on most of the cardio-metabolic risk factors (hypertension, hyperlipidemia, endothelial dysfunction and atherosclerosis) by regulating gene transcription factors [i.e., peroxisome proliferator-activated receptor (PPAR) α, PPARγ, sterol regulatory element-binding protein-1, carbohydrate responsive element-binding protein], impacts both lipid metabolism and on insulin sensitivity. In addition to an enhancement of hepatic beta oxidation and a decrease of the endogenous lipid production, n-3 PUFAs are able to determine a significant reduction of the expression of pro-inflammatory molecules (tumor necrosis factor-α and interleukin-6) and of oxygen reactive species. Further strengthening the results of the in vitro studies, both animal models and human intervention trials, showed a beneficial effect of n-3 PUFAs on the severity of NAFLD as expressed by laboratory parameters and imaging measurements. Despite available results provided encouraging data about the efficacy of n-3 PUFAs as a treatment of NAFLD in humans, well-designed randomized controlled trials of adequate size and duration, with histological endpoints, are needed to assess the long-term safety and efficacy of PUFA, as well as other therapies, for the treatment of NAFLD and non-alcoholic steatohepatitis patients. It is worthwhile to consider that n-3 PUFAs cannot be synthesized by the human body and must be derived from exogenous sources (fish oil, flaxseeds, olive oil) which are typical foods of the Mediterranean diet, known for its beneficial effects in preventing obesity, diabetes and, in turn, cardiovascular events. According to these data, it is important to consider that most of the beneficial effects of n-3 PUFAs can also be obtained by an equilibrate nutrition program." @default.
• W1497133247 created "2016-06-24" @default.
• W1497133247 creator A5001770956 @default.
• W1497133247 creator A5035490260 @default.
• W1497133247 creator A5041095834 @default.
• W1497133247 creator A5045618604 @default.
• W1497133247 creator A5053368792 @default.
• W1497133247 creator A5073001267 @default.
• W1497133247 date "2012-01-01" @default.
• W1497133247 modified "2023-10-15" @default.
• W1497133247 title "Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease" @default.
• W1497133247 cites W1534724641 @default.
• W1497133247 cites W1833553896 @default.
• W1497133247 cites W1917945682 @default.
• W1497133247 cites W1949441022 @default.
• W1497133247 cites W1971999946 @default.
• W1497133247 cites W1972709924 @default.
• W1497133247 cites W1974186154 @default.
• W1497133247 cites W1975453003 @default.
• W1497133247 cites W1978618107 @default.
• W1497133247 cites W1981152879 @default.
• W1497133247 cites W1982578021 @default.
• W1497133247 cites W1985032848 @default.
• W1497133247 cites W1986838881 @default.
• W1497133247 cites W1992958610 @default.
• W1497133247 cites W1993460622 @default.
• W1497133247 cites W2002333654 @default.
• W1497133247 cites W2004823251 @default.
• W1497133247 cites W2006162642 @default.
• W1497133247 cites W2006574739 @default.
• W1497133247 cites W2007809519 @default.
• W1497133247 cites W2012257654 @default.
• W1497133247 cites W2012860738 @default.
• W1497133247 cites W2015643123 @default.
• W1497133247 cites W2016993385 @default.
• W1497133247 cites W2018069376 @default.
• W1497133247 cites W2030532669 @default.
• W1497133247 cites W2033237984 @default.
• W1497133247 cites W2033829190 @default.
• W1497133247 cites W2034298464 @default.
• W1497133247 cites W2039678693 @default.
• W1497133247 cites W2040109162 @default.
• W1497133247 cites W2040727785 @default.
• W1497133247 cites W2040735050 @default.
• W1497133247 cites W2045308683 @default.
• W1497133247 cites W2051883615 @default.
• W1497133247 cites W2052981488 @default.
• W1497133247 cites W2053523592 @default.
• W1497133247 cites W2054242855 @default.
• W1497133247 cites W2056728315 @default.
• W1497133247 cites W2059142971 @default.
• W1497133247 cites W2059251195 @default.
• W1497133247 cites W2059269389 @default.
• W1497133247 cites W2069662492 @default.
• W1497133247 cites W2073915513 @default.
• W1497133247 cites W2074111219 @default.
• W1497133247 cites W2079072815 @default.
• W1497133247 cites W2079378050 @default.
• W1497133247 cites W2091876682 @default.
• W1497133247 cites W2093126082 @default.
• W1497133247 cites W2098232314 @default.
• W1497133247 cites W2102210313 @default.
• W1497133247 cites W2102656403 @default.
• W1497133247 cites W2103017585 @default.
• W1497133247 cites W2107261609 @default.
• W1497133247 cites W2107732097 @default.
• W1497133247 cites W2110319339 @default.
• W1497133247 cites W2111534524 @default.
• W1497133247 cites W2111696876 @default.
• W1497133247 cites W2113454882 @default.
• W1497133247 cites W2114472618 @default.
• W1497133247 cites W2116655531 @default.
• W1497133247 cites W2117147259 @default.
• W1497133247 cites W2119434148 @default.
• W1497133247 cites W2123300907 @default.
• W1497133247 cites W2123404136 @default.
• W1497133247 cites W2130064617 @default.
• W1497133247 cites W2132741387 @default.
• W1497133247 cites W2134258801 @default.
• W1497133247 cites W2136795008 @default.
• W1497133247 cites W2140656018 @default.
• W1497133247 cites W2144178804 @default.
• W1497133247 cites W2144591738 @default.
• W1497133247 cites W2146544786 @default.
• W1497133247 cites W2148521985 @default.
• W1497133247 cites W2149240150 @default.
• W1497133247 cites W2154164735 @default.
• W1497133247 cites W2155503613 @default.
• W1497133247 cites W2160131170 @default.
• W1497133247 cites W2164098551 @default.
• W1497133247 cites W2167485268 @default.
• W1497133247 cites W2167909421 @default.
• W1497133247 cites W2168568159 @default.
• W1497133247 cites W2409001433 @default.
• W1497133247 cites W3143753495 @default.
• W1497133247 cites W86187522 @default.
• W1497133247 doi "https://doi.org/10.3748/wjg.v18.i41.5839" @default.
• W1497133247 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3491590" @default.

• next